This promotes tumor development, highlighting the METTL16–MYC–GLUL–YTHDC1 axis as a key pathway in Cr(VI)-induced carcinogenesis and suggesting METTL16 as a potential therapeutic target for environmentally related cancers (16). Here, METTL16 is linked to neoplasm.